2025 RES-104
APPROVING THE PROPOSED SETTLEMENT OF OPIOID-RELATED CLAIMS AGAINST ALVOGEN, INC., AMNEAL PHARMACEUTICALS, INC., APOTEX, INC., HIKMA PHARMACEUTICALS USA, INC., INDIVIOR, INC., MYLAN PHARMACEUTICALS, INC., SUN PHARMACEUTICAL INDUSTRIES, INC., ZYDUS PHARMACEUTICALS, INC., AND PURDUE PHARMA, LLP AND THE SACKLER FAMILY
- Committee
- Personnel & Finance Committee
- Introduced
- July 16, 2025
- On agenda
- August 11, 2025
- Passed
- August 18, 2025